One company powers AI-driven cloud giants, while the other anchors enterprise voice worldwide. Examine their fundamentals, ...

The Erlanger case, which has not been previously reported, offers a rare glimpse at an apparent failure of AI drug diversion ...

Lantronix is transitioning from a legacy IoT hardware model to a platform-focused edge AI provider. Learn why LTRX stock is a ...

Washington keeps adopting tools that can shape, track or influence the federal workforce before Congress sets clear rules for ...

A North Carolina software engineer secured approval to avoid AI tools at her tech job on religious grounds. The case reflects ...

Humanoid robots are impressive, but companies should judge them by economics, reliability, and cost per task, not by how ...

Many companies went all-in on using AI. Then they got the bill.

Kim Custeau, AVEVA’s executive vice president of portfolio discusses AI, hybrid cloud infrastructure and operational data.

Are we at the peak of the AI stock boom or merely in the foothills? To answer that question, a good place to start is with Ed ...

Attorneys are using AI to analyze potential jurors, but experts warn the tech could introduce hidden biases.

Sentri7, drug diversion software powered by artificial intelligence and used at hundreds of U.S. hospitals, did not catch a ...